ERBB2 and breast cancer: Breast cancer is mainly divided into hormone receptor (HR) positive subtype, human epidermal growth factor 2 (HER2) positive subtype, and triple-negative subtype, showing different degrees of lipid dependence (Ward et al., 2021).